130 related articles for article (PubMed ID: 27104939)
1. Ovarian Yolk Sac Tumor: The Experience of a Regional Cancer Center.
Wang X; Ma Z; Li Y
Int J Gynecol Cancer; 2016 Jun; 26(5):884-91. PubMed ID: 27104939
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
[TBL] [Abstract][Full Text] [Related]
3. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
Xu W; Li Y
Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
[TBL] [Abstract][Full Text] [Related]
4. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
[TBL] [Abstract][Full Text] [Related]
5. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of patients with yolk sac tumors of the ovary.
Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
[TBL] [Abstract][Full Text] [Related]
7. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
Cushing B; Giller R; Ablin A; Cohen L; Cullen J; Hawkins E; Heifetz SA; Krailo M; Lauer SJ; Marina N; Rao PV; Rescorla F; Vinocur CD; Weetman RM; Castleberry RP
Am J Obstet Gynecol; 1999 Aug; 181(2):353-8. PubMed ID: 10454682
[TBL] [Abstract][Full Text] [Related]
8. Ovarian endometrioid-like yolk sac tumor treated by surgery alone, with recurrence at 12 years.
Kommoss F; Schmidt M; Merz E; Knapstein PG; Young RH; Scully RE
Gynecol Oncol; 1999 Mar; 72(3):421-4. PubMed ID: 10053117
[TBL] [Abstract][Full Text] [Related]
9. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
10. Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base.
Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Holcomb K
Gynecol Oncol; 2017 Nov; 147(2):296-301. PubMed ID: 28803748
[TBL] [Abstract][Full Text] [Related]
11. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
12. Trends in the surgical management of malignant ovarian germcell tumors.
Nasioudis D; Mastroyannis SA; Latif NA; Ko EM
Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791
[TBL] [Abstract][Full Text] [Related]
13. Acute abdomen secondary to rare yolk sac tumour.
Soleymani Majd H; Turner SA; Choji K; Lwin K; B-Lynch C
Arch Gynecol Obstet; 2009 May; 279(5):725-7. PubMed ID: 18795306
[TBL] [Abstract][Full Text] [Related]
14. Does omentectomy in epithelial ovarian cancer affect survival? An analysis of the Surveillance, Epidemiology, and End Results database.
McNally L; Teng NN; Kapp DS; Karam A
Int J Gynecol Cancer; 2015 May; 25(4):607-15. PubMed ID: 25756404
[TBL] [Abstract][Full Text] [Related]
15. The role of staging surgery in the treatment of apparent early-stage malignant ovarian germ cell tumours.
Zhao T; Zhang H; Liu Y; Jiang H; Wang X; Lu Y
Aust N Z J Obstet Gynaecol; 2016 Aug; 56(4):398-402. PubMed ID: 27135780
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman.
Isonishi S; Ogura A; Kiyokawa T; Suzuki M; Kunito S; Hirama M; Tachibana T; Ochiai K; Tanaka T
Int J Clin Oncol; 2009 Feb; 14(1):70-3. PubMed ID: 19225928
[TBL] [Abstract][Full Text] [Related]
18. [Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].
Liu Q; Ding XL; Yang JX; Cao DY; Shen K; Lang JH; Zhang GN; Xin XY; Xie X; Zhang SL; Wu YM; Zhu GH; Wang J; Chen YL; Kong BH; Zheng JH
Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):188-92. PubMed ID: 23849941
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome and prognostic factors for yolk sac tumor of the ovary.
Umezu T; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
Nagoya J Med Sci; 2008 Mar; 70(1-2):29-34. PubMed ID: 18807293
[TBL] [Abstract][Full Text] [Related]
20. Ovarian yolk sac tumor associated with major fibrosarcoma component in a 13-year-old girl.
Ali L; Bambach BJ; Kozielski R; Wagner H; Lele S; Mhawech-Fauceglia P
Int J Gynecol Pathol; 2010 May; 29(3):252-5. PubMed ID: 20407325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
